Asthma drug can block crucial SARS-CoV-2 protein

Researchers identify key regulators of urinary concentration in the kidney
25 April 2022
Promising biologic drug for treating chronic lung disease
25 April 2022

Asthma drug can block crucial SARS-CoV-2 protein

A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and reduce viral replication in human immune cells, according to a new study by researchers at the Indian Institute of Science (IISc).

Comments are closed.